Correlation Between India Globalization and Ayala Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both India Globalization and Ayala Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining India Globalization and Ayala Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between India Globalization Capital and Ayala Pharmaceuticals, you can compare the effects of market volatilities on India Globalization and Ayala Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in India Globalization with a short position of Ayala Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of India Globalization and Ayala Pharmaceuticals.

Diversification Opportunities for India Globalization and Ayala Pharmaceuticals

-0.33

Correlation Coefficient

India Globalization  Ayala Pharmaceuticals

Very good diversification

The 3 months correlation between India and Ayala is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding India Globalization Capital and Ayala Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ayala Pharmaceuticals and India Globalization is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on India Globalization Capital are associated (or correlated) with Ayala Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ayala Pharmaceuticals has no effect on the direction of India Globalization i.e., India Globalization and Ayala Pharmaceuticals go up and down completely randomly.

Pair Corralation between India Globalization and Ayala Pharmaceuticals

If you would invest  34.00  in India Globalization Capital on March 14, 2024 and sell it today you would earn a total of  11.00  from holding India Globalization Capital or generate 32.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	1.59%
Values	Daily Returns

India Globalization Capital  vs.  Ayala Pharmaceuticals

India Globalization

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in India Globalization Capital are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating technical and fundamental indicators, India Globalization exhibited solid returns over the last few months and may actually be approaching a breakup point.

Ayala Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ayala Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Ayala Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with India Globalization and Ayala Pharmaceuticals

The main advantage of trading using opposite India Globalization and Ayala Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if India Globalization position performs unexpectedly, Ayala Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ayala Pharmaceuticals will offset losses from the drop in Ayala Pharmaceuticals' long position.

The idea behind India Globalization Capital and Ayala Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.